HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 424 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.31 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $16,389 | +34.3% | 313 | +4.3% | 0.00% | – |
Q1 2024 | $12,204 | +10.1% | 300 | 0.0% | 0.00% | – |
Q4 2023 | $11,088 | -3.2% | 300 | 0.0% | 0.00% | – |
Q3 2023 | $11,460 | +5.9% | 300 | 0.0% | 0.00% | – |
Q2 2023 | $10,821 | -5.6% | 300 | 0.0% | 0.00% | – |
Q1 2023 | $11,457 | -84.5% | 300 | -76.9% | 0.00% | -100.0% |
Q4 2022 | $73,970 | +45.0% | 1,300 | 0.0% | 0.00% | 0.0% |
Q3 2022 | $51,000 | -10.5% | 1,300 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $57,000 | +307.1% | 1,300 | +271.4% | 0.00% | – |
Q3 2021 | $14,000 | -12.5% | 350 | 0.0% | 0.00% | – |
Q2 2021 | $16,000 | -100.0% | 350 | -79.4% | 0.00% | -100.0% |
Q1 2021 | $70,874,000 | +472393.3% | 1,700 | +385.7% | 0.00% | – |
Q4 2020 | $15,000 | -64.3% | 350 | -85.4% | 0.00% | -100.0% |
Q4 2019 | $42,000 | +13.5% | 2,400 | 0.0% | 0.00% | 0.0% |
Q3 2019 | $37,000 | -24.5% | 2,400 | -16.5% | 0.00% | -50.0% |
Q2 2019 | $49,000 | -14.0% | 2,875 | -8.1% | 0.00% | -33.3% |
Q3 2018 | $57,000 | +7.5% | 3,130 | -0.3% | 0.00% | 0.0% |
Q2 2018 | $53,000 | – | 3,140 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Third Security, LLC | 14,092,771 | $206,177,000 | 28.12% |
BB BIOTECH AG | 8,322,860 | $121,763,000 | 3.90% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 398,633 | $4,579,000 | 2.84% |
DOHENY ASSET MANAGEMENT /CA | 227,193 | $3,324,000 | 2.43% |
SNYDER CAPITAL MANAGEMENT L P | 2,833,759 | $41,458,000 | 2.24% |
First Light Asset Management, LLC | 938,399 | $13,729,000 | 2.19% |
IRIDIAN ASSET MANAGEMENT LLC/CT | 9,027,164 | $132,067,000 | 1.77% |
Taylor Wealth Management Partners | 204,277 | $2,989,000 | 1.72% |
Sterling Global Strategies LLC | 22,000 | $321,860,000 | 1.63% |
Granite Investment Partners, LLC | 988,939 | $14,468,000 | 1.06% |